Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.

Autor: Fassas A; George Papanicolaou General Hospital, Dpt. Hematology, 57010 Thessaloniki, Greece. hempap@otenet.gr, Passweg JR, Anagnostopoulos A, Kazis A, Kozak T, Havrdova E, Carreras E, Graus F, Kashyap A, Openshaw H, Schipperus M, Deconinck E, Mancardi G, Marmont A, Hansz J, Rabusin M, Zuazu Nagore FJ, Besalduch J, Dentamaro T, Fouillard L, Hertenstein B, La Nasa G, Musso M, Papineschi F, Rowe JM, Saccardi R, Steck A, Kappos L, Gratwohl A, Tyndall A, Samijn J

Publikováno v: Journal of neurology [J Neurol] 2002 Aug; Vol. 249 (8), pp. 1088-97.

Transplantation of retrovirally transduced bone marrow prevents autoimmune disease in aged mice by peripheral tolerance mechanisms.

Autor: Chen, Xiang T.¹ (AUTHOR), Chan, Siow T.¹ (AUTHOR), Hosseini, Hamid¹ (AUTHOR), Layton, Daniel² (AUTHOR), Boyd, Richard² (AUTHOR), Alderuccio, Frank³ (AUTHOR), Toh, Ban-Hock¹ (AUTHOR), Chan, James¹ (AUTHOR) james.chan@monash.edu

Publikováno v: Autoimmunity. Aug2011, Vol. 44 Issue 5, p384-393. 10p.

Immune reconstitution therapy (IRT) in multiple sclerosis: the rationale.

Autor: Karussis, Dimitrios, Petrou, Panayiota

Publikováno v: Immunologic Research; Dec2018, Vol. 66 Issue 6, p642-648, 7p

Campath 1-H treatment in patients with aggressive relapsing remitting multiple sclerosis.

Autor: Hirst, C. L., Pace, A., Pickersgill, T. P., Jones, R., McLean, B. N., Zajicek, J. P., Scolding, N. J., Robertson, N. P.

Publikováno v: Journal of Neurology; Feb2008, Vol. 255 Issue 2, p231-238, 8p, 1 Chart, 2 Graphs

Alternatives to current disease-modifying treatment in MS: what do we need and what can we expect in the future?

Autor: Kappos, Ludwig, Kuhle, Jens, Gass, Achim, Achtnichts, Lutz, Radue, Ernst-Wilhelm

Publikováno v: Journal of Neurology; May2004 Supplement 5, Vol. 251, pv57-v64, 8p